Detalhe da pesquisa
1.
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation.
Lancet;
403(10422): e2-e4, 2024 Jan 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36774936
2.
New business models for pharmaceutical research and development as a global public good: considerations for the WHO European Region
Oslo Medicines Initiative technical report;
Monografia
em Inglês
| WHOLIS
| ID: who-361752